European regulators have given Stimwave Technologies CE mark approval for its SandShark Percutaneous Injectable Anchor System, which is intended for use with the company's wireless neurostimulator devices in treating patients with chronic pain. The system allows a stimulator and its anchor to be injected through the same needle puncture port.
Stimwave's percutaneous injectable anchor system wins EU nod
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.